The MIT Enterprise Forum, a networking organization for entrepreneurs, said today that Richard Kivel has been named as chairman of its global board of directors. Kivel, a member of the Enterprise Forum’s board since 2006, is the CEO of TheraGenetics, a personalized medicine company based in London. He replaces Joe Hadzima, managing director of Main Street Partners, a venture development and commercialization firm in Cambridge, MA.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
